Find XO: Where Software Founders Fit in the AI Drug Discovery Startup Boom (wsj.com)

- Reid Hoffman and Siddhartha Mukherji launched Manas AI, an AI drug discovery startup, with a $24.6 million seed round. - It's a small amount compared to other companies raising $1.3 billion. - Software founders without biotech backgrounds should focus on the underlying platform and data layers rather than competing directly in drug creation. - If aiming to reduce researchers' time, confirm actual demand and work with colleagues who have biotech expertise.